<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34440761</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1992</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10081992</ELocationID><Abstract><AbstractText>Neurodegenerative diseases are characterized by the progressive loss of structure and/or function of both neurons and glial cells, leading to different degrees of pathology and loss of cognition. The hypothesis of circuit reconstruction in the damaged brain via direct cell replacement has been pursued extensively so far. In this context, stem cells represent a useful option since they provide tissue restoration through the substitution of damaged neuronal cells with exogenous stem cells and create a neuro-protective environment through the release of bioactive molecules for healthy neurons, as well. These peculiar properties of stem cells are opening to potential therapeutic strategies for the treatment of severe neurodegenerative disorders, for which the absence of effective treatment options leads to an increasingly socio-economic burden. Currently, the introduction of new technologies in the field of stem cells and the implementation of alternative cell tissues sources are pointing to exciting frontiers in this area of research. Here, we provide an update of the current knowledge about source and administration routes of stem cells, and review light and shadows of cells replacement therapy for the treatment of the three main neurodegenerative disorders (Amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's disease).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonaventura</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation (IRIB), Italian National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munaf&#xf2;</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellanca</LastName><ForeName>Carlo Maria</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Cognata</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation (IRIB), Italian National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iemmolo</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9297-8115</Identifier><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation (IRIB), Italian National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attaguile</LastName><ForeName>Giuseppe Antonino</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Mauro</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Benedetto</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantarella</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcellona</LastName><ForeName>Maria Luisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department Pharmaceutical Science, Biochemistry Section, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallaro</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7590-1792</Identifier><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation (IRIB), Italian National Research Council, 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardini</LastName><ForeName>Renato</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department Biomedical and Biotechnological Sciences (BIOMETEC), Section of Pharmacology, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="Y">Nerve Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009416" MajorTopicYN="Y">Nerve Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058953" MajorTopicYN="N">Neural Stem Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000637" MajorTopicYN="Y">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015213" MajorTopicYN="N">Neuroimmunomodulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="Y">Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">immunomodulation</Keyword><Keyword MajorTopicYN="N">stem cell therapy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34440761</ArticleId><ArticleId IdType="pmc">PMC8391848</ArticleId><ArticleId IdType="doi">10.3390/cells10081992</ArticleId><ArticleId IdType="pii">cells10081992</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fuchs E., Chen T. A matter of life and death: Self-renewal in stem cells. EMBO Rep. 2013;14:39&#x2013;48. doi: 10.1038/embor.2012.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2012.197</ArticleId><ArticleId IdType="pmc">PMC3537149</ArticleId><ArticleId IdType="pubmed">23229591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakrzewski W., Dobrzy&#x144;ski M., Szymonowicz M., Rybak Z. Stem cells: Past, present, and future. Stem Cell Res. Ther. 2019;10:1&#x2013;22. doi: 10.1186/s13287-019-1165-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-019-1165-5</ArticleId><ArticleId IdType="pmc">PMC6390367</ArticleId><ArticleId IdType="pubmed">30808416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakthiswary R., Raymond A.A. Stem cell therapy in neurodegenerative diseases: From principles to practice. Neural Regen. Res. 2012;7:1822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302533</ArticleId><ArticleId IdType="pubmed">25624807</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Peng Y., Zeng H., Chen G. Progress in mesenchymal stem cell therapy for ischemic stroke. Stem Cells Int. 2021;2021:9923566. doi: 10.1155/2021/9923566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9923566</ArticleId><ArticleId IdType="pmc">PMC8219421</ArticleId><ArticleId IdType="pubmed">34221026</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns T.C., Quinones-Hinojosa A. Regenerative medicine for neurological diseases&#x2014;will regenerative neurosurgery deliver? BMJ. 2021;373:955. doi: 10.1136/bmj.n955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n955</ArticleId><ArticleId IdType="pubmed">34162530</ArticleId></ArticleIdList></Reference><Reference><Citation>Martirosyan N.L. Pharmacologic and cell-based therapies for acute spinal cord injury. Neurosurg. Clin. 2021;32:389&#x2013;395. doi: 10.1016/j.nec.2021.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nec.2021.03.010</ArticleId><ArticleId IdType="pubmed">34053726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla C., Zurita M. Cell-based therapies for traumatic brain injury: Therapeutic treatments and clinical trials. Biomedicines. 2021;9:669. doi: 10.3390/biomedicines9060669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9060669</ArticleId><ArticleId IdType="pmc">PMC8230536</ArticleId><ArticleId IdType="pubmed">34200905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ager R.R., Davis J.L., Agazaryan A., Benavente F., Poon W.W., LaFerla F.M., Blurton-Jones M. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer&#x2019;s disease and neuronal loss. Hippocampus. 2015;25:813&#x2013;826. doi: 10.1002/hipo.22405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22405</ArticleId><ArticleId IdType="pmc">PMC4722865</ArticleId><ArticleId IdType="pubmed">25530343</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu A.Y., Rao M.S. Cell-based therapy for neural disorders--anticipating challenges. Neurother. J. Am. Soc. Exp. NeuroTherapeutics. 2011;8:744&#x2013;752. doi: 10.1007/s13311-011-0066-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-011-0066-9</ArticleId><ArticleId IdType="pmc">PMC3250286</ArticleId><ArticleId IdType="pubmed">21901585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan S.F., Sances S., Brill L.M., Okamoto S., Zaidi R., McKercher S.R., Akhtar M.W., Nakanishi N., Lipton S.A. ATM-dependent phosphorylation of MEF2D promotes neuronal survival after DNA damage. J. Neurosci. Off. J. Soc. Neurosci. 2014;34:4640&#x2013;4653. doi: 10.1523/JNEUROSCI.2510-12.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2510-12.2014</ArticleId><ArticleId IdType="pmc">PMC3965787</ArticleId><ArticleId IdType="pubmed">24672010</ArticleId></ArticleIdList></Reference><Reference><Citation>Condic M.L. Totipotency: What it is and what it is not. Stem Cells Dev. 2014;23:796&#x2013;812. doi: 10.1089/scd.2013.0364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2013.0364</ArticleId><ArticleId IdType="pmc">PMC3991987</ArticleId><ArticleId IdType="pubmed">24368070</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., David B.T., Trawczynski M., Fessler R.G. Advances in pluripotent stem cells: History, mechanisms, technologies, and applications. Stem Cell Rev. Rep. 2020;16:3&#x2013;32. doi: 10.1007/s12015-019-09935-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-019-09935-x</ArticleId><ArticleId IdType="pmc">PMC6987053</ArticleId><ArticleId IdType="pubmed">31760627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Belmonte J.C.I. Stem cells: A renaissance in human biology research. Cell. 2016;165:1572&#x2013;1585. doi: 10.1016/j.cell.2016.05.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.043</ArticleId><ArticleId IdType="pubmed">27315475</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproul A.A., Jacob S., Pre D., Kim S.H., Nestor M.W., Navarro-Sobrino M., Santa-Maria I., Zimmer M., Aubry S., Steele J.W., et al. Characterization and molecular profiling of PSEN1 familial Alzheimer&#x2019;s disease iPSC-derived neural progenitors. PLoS ONE. 2014;9:e84547. doi: 10.1371/journal.pone.0084547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0084547</ArticleId><ArticleId IdType="pmc">PMC3885572</ArticleId><ArticleId IdType="pubmed">24416243</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663&#x2013;676. doi: 10.1016/j.cell.2006.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.07.024</ArticleId><ArticleId IdType="pubmed">16904174</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861&#x2013;872. doi: 10.1016/j.cell.2007.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.11.019</ArticleId><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo N.-N., Liu L.-P., Zheng Y.-W., Li Y.-M. Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach. World J. Stem Cells. 2020;12:25. doi: 10.4252/wjsc.v12.i1.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v12.i1.25</ArticleId><ArticleId IdType="pmc">PMC7031760</ArticleId><ArticleId IdType="pubmed">32110273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y.J., Do J.T. Neural lineage differentiation from pluripotent stem cells to mimic human brain tissues. Front. Bioeng. Biotechnol. 2019;7:400. doi: 10.3389/fbioe.2019.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2019.00400</ArticleId><ArticleId IdType="pmc">PMC6908493</ArticleId><ArticleId IdType="pubmed">31867324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong P., Xie X., Li F., Liu Y., Lu Y. Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem. Biophys. Res. Commun. 2013;438:410&#x2013;419. doi: 10.1016/j.bbrc.2013.07.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.07.088</ArticleId><ArticleId IdType="pubmed">23899518</ArticleId></ArticleIdList></Reference><Reference><Citation>Magatti M., Vertua E., De Munari S., Caro M., Caruso M., Silini A., Delgado M., Parolini O. Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features. J. Tissue Eng. Regen. Med. 2017;11:2895&#x2013;2911. doi: 10.1002/term.2193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.2193</ArticleId><ArticleId IdType="pmc">PMC5697700</ArticleId><ArticleId IdType="pubmed">27396853</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J. Cell Biochem. 2006;98:1076&#x2013;1084. doi: 10.1002/jcb.20886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.20886</ArticleId><ArticleId IdType="pubmed">16619257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., Van Griensven M., Stadler G., Redl H., Gabriel C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007;13:1173&#x2013;1183. doi: 10.1089/ten.2006.0313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ten.2006.0313</ArticleId><ArticleId IdType="pubmed">17518752</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon C., Ryan J., Sobrevia L., Kobayashi M., Ashman K., Mitchell M., Rice G.E. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS ONE. 2013;8:e68451. doi: 10.1371/journal.pone.0068451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068451</ArticleId><ArticleId IdType="pmc">PMC3704530</ArticleId><ArticleId IdType="pubmed">23861904</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Z., Jin J., Chen L., Zhu J., Huang W., Zhao J., Qian H., Zhang X. Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int. 2006;30:681&#x2013;687. doi: 10.1016/j.cellbi.2006.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellbi.2006.03.009</ArticleId><ArticleId IdType="pubmed">16870478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson A., Frenette P.S. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat. Med. 2014;20:833&#x2013;846. doi: 10.1038/nm.3647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3647</ArticleId><ArticleId IdType="pmc">PMC4459580</ArticleId><ArticleId IdType="pubmed">25100529</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Angelo M., Cimini A., Castelli V. Insights into the effects of mesenchymal stem cell-derived secretome in Parkinson&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:5241. doi: 10.3390/ijms21155241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155241</ArticleId><ArticleId IdType="pmc">PMC7432166</ArticleId><ArticleId IdType="pubmed">32718092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Zhou L., Gao X., Chen B., Tu J., Sun H., Liu X., He J., Liu J., Yuan Q. Neuroprotective effects of bone marrow stem cells overexpressing glial cell line-derived neurotrophic factor on rats with intracerebral hemorrhage and neurons exposed to hypoxia/reoxygenation. Neurosurgery. 2011;68:691&#x2013;704. doi: 10.1227/NEU.0b013e3182098a8a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0b013e3182098a8a</ArticleId><ArticleId IdType="pubmed">21311297</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Jiang Q., Ding G., Zhang L., Zhang Z.G., Li Q., Panda S., Lu M., Ewing J.R., Chopp M. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J. Cereb. Blood Flow Metab. 2010;30:653&#x2013;662. doi: 10.1038/jcbfm.2009.238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2009.238</ArticleId><ArticleId IdType="pmc">PMC2844252</ArticleId><ArticleId IdType="pubmed">19888287</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra V., Lal A., El Khoury R., Chen P.R., Savitz S.I. Intra-arterial delivery of cell therapies for stroke. Stem Cells Dev. 2012;21:1007&#x2013;1015. doi: 10.1089/scd.2011.0612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2011.0612</ArticleId><ArticleId IdType="pmc">PMC3328761</ArticleId><ArticleId IdType="pubmed">22181047</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Ye R., Yan T., Yu S.P., Wei L., Xu G., Fan X., Jiang Y., Stetler R.A., Liu G. Cell based therapies for ischemic stroke: From basic science to bedside. Prog. Neurobiol. 2014;115:92&#x2013;115. doi: 10.1016/j.pneurobio.2013.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2013.11.007</ArticleId><ArticleId IdType="pmc">PMC4038267</ArticleId><ArticleId IdType="pubmed">24333397</ArticleId></ArticleIdList></Reference><Reference><Citation>Savitz S.I., Dinsmore J., Wu J., Henderson G.V., Stieg P., Caplan L.R. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc. Dis. 2005;20:101&#x2013;107. doi: 10.1159/000086518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000086518</ArticleId><ArticleId IdType="pubmed">15976503</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich S., Seledtsov V., Banul N., Poveshchenko O., Senyukov V., Astrakov S., Samarin D., Taraban V.Y. Cell therapy of brain stroke. Bull. Exp. Biol. Med. 2005;139:126&#x2013;128. doi: 10.1007/s10517-005-0229-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10517-005-0229-y</ArticleId><ArticleId IdType="pubmed">16142294</ArticleId></ArticleIdList></Reference><Reference><Citation>Du S., Guan J., Mao G., Liu Y., Ma S., Bao X., Gao J., Feng M., Li G., Ma W. Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats. Cell Transplant. 2014;23:73&#x2013;82. doi: 10.3727/096368914X685023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368914X685023</ArticleId><ArticleId IdType="pubmed">25372507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacigaluppi M., Pluchino S., Martino G., Kilic E., Hermann D.M. Neural stem/precursor cells for the treatment of ischemic stroke. J. Neurol. Sci. 2008;265:73&#x2013;77. doi: 10.1016/j.jns.2007.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.06.012</ArticleId><ArticleId IdType="pubmed">17610905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiya N., Ueda M., Igarashi H., Nishiyama Y., Suda S., Inaba T., Katayama Y. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci. 2008;83:433&#x2013;437. doi: 10.1016/j.lfs.2008.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2008.07.018</ArticleId><ArticleId IdType="pubmed">18727931</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendharkar A.V., Chua J.Y., Andres R.H., Wang N., Gaeta X., Wang H., De A., Choi R., Chen S., Rutt B.K. Biodistribution of neural stem cells after intravascular therapy for hypoxic&#x2013;ischemia. Stroke. 2010;41:2064&#x2013;2070. doi: 10.1161/STROKEAHA.109.575993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.575993</ArticleId><ArticleId IdType="pmc">PMC4831577</ArticleId><ArticleId IdType="pubmed">20616329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Li Y., Romanko M., Kramer B.C., Gosiewska A., Chopp M., Hong K. Different routes of administration of human umbilical tissue-derived cells improve functional recovery in the rat after focal cerebral ischemia. Brain Res. 2012;1489:104&#x2013;112. doi: 10.1016/j.brainres.2012.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.10.017</ArticleId><ArticleId IdType="pubmed">23063717</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak P., Zhang J., Gilad A.A., Kedziorek D.A., Ruiz-Cabello J., Young R.G., Pittenger M.F., Van Zijl P.C., Huang J., Bulte J.W. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;39:1569&#x2013;1574. doi: 10.1161/STROKEAHA.107.502047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.107.502047</ArticleId><ArticleId IdType="pmc">PMC2857730</ArticleId><ArticleId IdType="pubmed">18323495</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielyan L., Sch&#xe4;fer R., von Ameln-Mayerhofer A., Bernhard F., Verleysdonk S., Buadze M., Lourhmati A., Klopfer T., Schaumann F., Schmid B. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res. 2011;14:3&#x2013;16. doi: 10.1089/rej.2010.1130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/rej.2010.1130</ArticleId><ArticleId IdType="pubmed">21291297</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitz M., Demestre M., Sedlacik J., Meissner H., Fiehler J., Kim S.U., Westphal M., Schmidt N.O. Intranasal delivery of neural stem/progenitor cells: A noninvasive passage to target intracerebral glioma. Stem Cells Transl. Med. 2012;1:866&#x2013;873. doi: 10.5966/sctm.2012-0045.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2012-0045</ArticleId><ArticleId IdType="pmc">PMC3659670</ArticleId><ArticleId IdType="pubmed">23283548</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Velthoven C.T., Sheldon R.A., Kavelaars A., Derugin N., Vexler Z.S., Willemen H.L., Maas M., Heijnen C.J., Ferriero D.M. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke. 2013;44:1426&#x2013;1432. doi: 10.1161/STROKEAHA.111.000326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.000326</ArticleId><ArticleId IdType="pmc">PMC3694433</ArticleId><ArticleId IdType="pubmed">23539530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei N., Yu S.P., Gu X., Taylor T.M., Song D., Liu X.-f., Wei L. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant. 2013;22:977&#x2013;991. doi: 10.3727/096368912X657251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368912X657251</ArticleId><ArticleId IdType="pubmed">23031629</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijboer C.H., Kooijman E., Van Velthoven C.T., Van Tilborg E., Tiebosch I.A., Eijkelkamp N., Dijkhuizen R.M., Kesecioglu J., Heijnen C.J. Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage. Stem Cells Dev. 2018;27:313&#x2013;325. doi: 10.1089/scd.2017.0148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2017.0148</ArticleId><ArticleId IdType="pubmed">29310519</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X., Liu G., Halim A., Ju Y., Luo Q., Song G. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8:784. doi: 10.3390/cells8080784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8080784</ArticleId><ArticleId IdType="pmc">PMC6721499</ArticleId><ArticleId IdType="pubmed">31357692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lochhead J.J., Thorne R.G. Intranasal delivery of biologics to the central nervous system. Adv. Drug Deliv. Rev. 2012;64:614&#x2013;628. doi: 10.1016/j.addr.2011.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2011.11.002</ArticleId><ArticleId IdType="pubmed">22119441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay S.L., Barnett S.C. Therapeutic Potential of Niche-Specific Mesenchymal Stromal Cells for Spinal Cord Injury Repair. Cells. 2021;10:901. doi: 10.3390/cells10040901.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10040901</ArticleId><ArticleId IdType="pmc">PMC8070966</ArticleId><ArticleId IdType="pubmed">33919910</ArticleId></ArticleIdList></Reference><Reference><Citation>Veneruso V., Rossi F., Villella A., Bena A., Forloni G., Veglianese P. Stem cell paracrine effect and delivery strategies for spinal cord injury regeneration. J. Control. Release. 2019;300:141&#x2013;153. doi: 10.1016/j.jconrel.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2019.02.038</ArticleId><ArticleId IdType="pubmed">30851286</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizoso F.J., Eiro N., Cid S., Schneider J., Perez-Fernandez R. Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine. Int. J. Mol. Sci. 2017;18:1852. doi: 10.3390/ijms18091852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091852</ArticleId><ArticleId IdType="pmc">PMC5618501</ArticleId><ArticleId IdType="pubmed">28841158</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawaz M., Camussi G., Valadi H., Nazarenko I., Ekstr&#xf6;m K., Wang X., Principe S., Shah N., Ashraf N.M., Fatima F. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat. Rev. Urol. 2014;11:688&#x2013;701. doi: 10.1038/nrurol.2014.301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrurol.2014.301</ArticleId><ArticleId IdType="pubmed">25403245</ArticleId></ArticleIdList></Reference><Reference><Citation>Belair C., Sim S., Kim K.-Y., Tanaka Y., Park I.-H., Wolin S.L. The RNA exosome nuclease complex regulates human embryonic stem cell differentiation. J. Cell Biol. 2019;218:2564&#x2013;2582. doi: 10.1083/jcb.201811148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201811148</ArticleId><ArticleId IdType="pmc">PMC6683745</ArticleId><ArticleId IdType="pubmed">31308215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorabi A.M., Kiaie N., Barreto G.E., Read M.I., Tafti H.A., Sahebkar A. The therapeutic potential of mesenchymal stem cell&#x2013;derived exosomes in treatment of neurodegenerative diseases. Mol. Neurobiol. 2019;56:8157&#x2013;8167. doi: 10.1007/s12035-019-01663-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01663-0</ArticleId><ArticleId IdType="pubmed">31197655</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarmalavi&#x10d;i&#x16b;t&#x117; A., Tunaitis V., Pivorait&#x117; U., Venalis A., Pivori&#x16b;nas A. Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine&#x2013;induced apoptosis. Cytotherapy. 2015;17:932&#x2013;939. doi: 10.1016/j.jcyt.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2014.07.013</ArticleId><ArticleId IdType="pubmed">25981557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.-S., Kim H.S., Park J.-M., Kim H.W., Park M.-K., Lee H.-S., Lim D.S., Lee T.H., Chopp M., Moon J. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer&#x2019;s disease model. Neurobiol. Aging. 2013;34:2408&#x2013;2420. doi: 10.1016/j.neurobiolaging.2013.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.03.029</ArticleId><ArticleId IdType="pubmed">23623603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokaia Z., Martino G., Schwartz M., Lindvall O. Cross-talk between neural stem cells and immune cells: The key to better brain repair? Nat. Neurosci. 2012;15:1078&#x2013;1087. doi: 10.1038/nn.3163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3163</ArticleId><ArticleId IdType="pubmed">22837038</ArticleId></ArticleIdList></Reference><Reference><Citation>Vader P., Mol E.A., Pasterkamp G., Schiffelers R.M. Extracellular vesicles for drug delivery. Adv. Drug Deliv. Rev. 2016;106:148&#x2013;156. doi: 10.1016/j.addr.2016.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2016.02.006</ArticleId><ArticleId IdType="pubmed">26928656</ArticleId></ArticleIdList></Reference><Reference><Citation>Association A.S. 2019 Alzheimer&#x2019;s disease facts and figures. Alzheimer&#x2019;s Dement. 2019;15:321&#x2013;387. doi: 10.1016/j.jalz.2019.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Patwardhan A.G., Belemkar S. An update on Alzheimer&#x2019;s disease: Immunotherapeutic agents, stem cell therapy and gene editing. Life Sci. 2021;282:119790. doi: 10.1016/j.lfs.2021.119790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119790</ArticleId><ArticleId IdType="pubmed">34245772</ArticleId></ArticleIdList></Reference><Reference><Citation>Krivanek T.J., Gale S.A., McFeeley B.M., Nicastri C.M., Daffner K.R. Promoting Successful Cognitive Aging: A Ten-Year Update. J. Alzheimer's Dis. 2021;81:871&#x2013;920. doi: 10.3233/JAD-201462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201462</ArticleId><ArticleId IdType="pmc">PMC8293659</ArticleId><ArticleId IdType="pubmed">33935078</ArticleId></ArticleIdList></Reference><Reference><Citation>Busche M.A., Hyman B.T. Synergy between amyloid-&#x3b2; and tau in Alzheimer&#x2019;s disease. Nat. Neurosci. 2020;23:1183&#x2013;1193. doi: 10.1038/s41593-020-0687-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0687-6</ArticleId><ArticleId IdType="pubmed">32778792</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal D.R., Walter J., Saido T.C., F&#xe4;ndrich M. Neuropathology and biochemistry of A&#x3b2; and its aggregates in Alzheimer&#x2019;s disease. Acta Neuropathol. 2015;129:167&#x2013;182. doi: 10.1007/s00401-014-1375-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1375-y</ArticleId><ArticleId IdType="pubmed">25534025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Zhao C., Qiu Y., Zhou Z., Bao J., Qian W. Dendritic/post-synaptic tau and early pathology of Alzheimer&#x2019;s disease. Front. Mol. Neurosci. 2021;14:127. doi: 10.3389/fnmol.2021.671779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.671779</ArticleId><ArticleId IdType="pmc">PMC8270001</ArticleId><ArticleId IdType="pubmed">34248498</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom G.S. Amyloid-&#x3b2; and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71:505&#x2013;508. doi: 10.1001/jamaneurol.2013.5847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.5847</ArticleId><ArticleId IdType="pubmed">24493463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen D.V., Hanson J.E., Sheng M. Microglia in Alzheimer&#x2019;s disease. J. Cell Biol. 2018;217:459&#x2013;472. doi: 10.1083/jcb.201709069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201709069</ArticleId><ArticleId IdType="pmc">PMC5800817</ArticleId><ArticleId IdType="pubmed">29196460</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgaletto C., Munaf&#xf2; A., Di Benedetto G., De Francisci C., Caraci F., Di Mauro R., Bucolo C., Bernardini R., Cantarella G. The immune system on the TRAIL of Alzheimer&#x2019;s disease. J. Neuroinflamm. 2020;17:1&#x2013;11. doi: 10.1186/s12974-020-01968-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01968-1</ArticleId><ArticleId IdType="pmc">PMC7556967</ArticleId><ArticleId IdType="pubmed">33050925</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe D.J., Hardy J. The amyloid hypothesis of Alzheimer&#x2019;s disease at 25 years. EMBO Mol. Med. 2016;8:595&#x2013;608. doi: 10.15252/emmm.201606210.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606210</ArticleId><ArticleId IdType="pmc">PMC4888851</ArticleId><ArticleId IdType="pubmed">27025652</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalivaeva N.N., Turner A.J. Targeting amyloid clearance in Alzheimer&#x2019;s disease as a therapeutic strategy. Br. J. Pharmacol. 2019;176:3447&#x2013;3463. doi: 10.1111/bph.14593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14593</ArticleId><ArticleId IdType="pmc">PMC6715594</ArticleId><ArticleId IdType="pubmed">30710367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillit H., Green A. Aducanumab and the FDA&#x2014;Where are we now? Nat. Rev. Neurol. 2021;17:129&#x2013;130. doi: 10.1038/s41582-020-00454-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00454-9</ArticleId><ArticleId IdType="pubmed">33442064</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider L. A resurrection of aducanumab for Alzheimer&#x2019;s disease. Lancet. Neurol. 2020;19:111&#x2013;112. doi: 10.1016/S1474-4422(19)30480-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30480-6</ArticleId><ArticleId IdType="pubmed">31978357</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard E., den Brok M.G., van Gool W.A. Bayes analysis supports null hypothesis of anti-amyloid beta therapy in Alzheimer&#x2019;s disease. Alzheimers. Dement. 2021;17:1051&#x2013;1055. doi: 10.1002/alz.12379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12379</ArticleId><ArticleId IdType="pmc">PMC8251763</ArticleId><ArticleId IdType="pubmed">34057297</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.-C., Yu J.-T., Wang H.-F., Tan M.-S., Meng X.-F., Wang C., Jiang T., Zhu X.-C., Tan L. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer&#x2019;s disease: A systematic review and meta-analysis. J. Alzheimer&#x2019;s Dis. 2014;41:615&#x2013;631. doi: 10.3233/JAD-132690.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-132690</ArticleId><ArticleId IdType="pubmed">24662102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J., Lee G., Ritter A., Sabbagh M., Zhong K. Alzheimer&#x2019;s disease drug development pipeline: 2019. Alzheimer&#x2019;s Dement. Transl. Res. Clin. Interv. 2019;5:272&#x2013;293. doi: 10.1016/j.trci.2019.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.05.008</ArticleId><ArticleId IdType="pmc">PMC6617248</ArticleId><ArticleId IdType="pubmed">31334330</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Leon J.A., Caceres-Palomo L., Sanchez-Mejias E., Mejias-Ortega M., Nu&#xf1;ez-Diaz C., Fernandez-Valenzuela J.J., Sanchez-Varo R., Davila J.C., Vitorica J., Gutierrez A. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:6867. doi: 10.3390/ijms21186867.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186867</ArticleId><ArticleId IdType="pmc">PMC7558359</ArticleId><ArticleId IdType="pubmed">32962164</ArticleId></ArticleIdList></Reference><Reference><Citation>Mungenast A.E., Siegert S., Tsai L.-H. Modeling Alzheimer&#x2019;s disease with human induced pluripotent stem (iPS) cells. Mol. Cell. Neurosci. 2016;73:13&#x2013;31. doi: 10.1016/j.mcn.2015.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.11.010</ArticleId><ArticleId IdType="pmc">PMC5930170</ArticleId><ArticleId IdType="pubmed">26657644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Lee D., Chang E.H., Kim J.H., Hwang J.W., Kim J.-Y., Kyung J.W., Kim S.H., Oh J.S., Shim S.M. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer&#x2019;s disease model. Stem Cells Dev. 2015;24:2378&#x2013;2390. doi: 10.1089/scd.2014.0487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2014.0487</ArticleId><ArticleId IdType="pmc">PMC4598918</ArticleId><ArticleId IdType="pubmed">26154268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Jia Y., Liu J., Zhai J., Cao N., Yue W., He H., Pei X. Dental pulp stem cells promote regeneration of damaged neuron cells on the cellular model of Alzheimer&#x2019;s disease. Cell Biol. Int. 2017;41:639&#x2013;650. doi: 10.1002/cbin.10767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.10767</ArticleId><ArticleId IdType="pubmed">28328017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilja A.M., Malmsten L., R&#xf6;jdner J., Voytenko L., Verkhratsky A., &#xd6;gren S.O., Nordberg A., Marutle A. Neural stem cell transplant-induced effect on neurogenesis and cognition in Alzheimer Tg2576 mice is inhibited by concomitant treatment with amyloid-lowering or cholinergic 7 nicotinic receptor drugs. Neural Plasticity. 2015;13:2015. doi: 10.1155/2015/370432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/370432</ArticleId><ArticleId IdType="pmc">PMC4518185</ArticleId><ArticleId IdType="pubmed">26257960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki T.R., Blurton-Jones M., Morrissette D.A., Kitazawa M., Oddo S., LaFerla F.M. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J. Neurosci. 2007;27:11925&#x2013;11933. doi: 10.1523/JNEUROSCI.1627-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1627-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673368</ArticleId><ArticleId IdType="pubmed">17978032</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J.Y., Park H.J., Kim H.N., Oh S.H., Bae J.-S., Ha H.-J., Lee P.H. Mesenchymal stem cells enhance autophagy and increase &#x3b2;-amyloid clearance in Alzheimer disease models. Autophagy. 2014;10:32&#x2013;44. doi: 10.4161/auto.26508.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.26508</ArticleId><ArticleId IdType="pmc">PMC4389879</ArticleId><ArticleId IdType="pubmed">24149893</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali P., K Lahiri D., Banik A., Nehru B., Anand A. Potential for stem cells therapy in Alzheimer&#x2019;s disease: Do neurotrophic factors play critical role? Curr. Alzheimer Res. 2017;14:208&#x2013;220. doi: 10.2174/1567205013666160314145347.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205013666160314145347</ArticleId><ArticleId IdType="pmc">PMC5880623</ArticleId><ArticleId IdType="pubmed">26971940</ArticleId></ArticleIdList></Reference><Reference><Citation>Volarevic V., Markovic B.S., Gazdic M., Volarevic A., Jovicic N., Arsenijevic N., Armstrong L., Djonov V., Lako M., Stojkovic M. Ethical and safety issues of stem cell-based therapy. Int. J. Med Sci. 2018;15:36. doi: 10.7150/ijms.21666.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.21666</ArticleId><ArticleId IdType="pmc">PMC5765738</ArticleId><ArticleId IdType="pubmed">29333086</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetani L., Paoletti F.P., Bellomo G., Mancini A., Simoni S., Di Filippo M., Parnetti L. CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment. Trends Pharmacol. Sci. 2020;2020.41:1023&#x2013;1037. doi: 10.1016/j.tips.2020.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.09.011</ArticleId><ArticleId IdType="pubmed">33127098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. New Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial amyotrophic lateral sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C.A., Lally C., Kupelian V., Flanders W.D. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants. Neuroepidemiology. 2021;9:1&#x2013;12. doi: 10.1159/000516752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516752</ArticleId><ArticleId IdType="pubmed">34247168</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Beltran S., Bakkouche S., Couratier P. Therapeutic news in ALS. Revue. Neurologique. 2021. 177:544&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">33781562</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucchia M., Ramirez A., Parente V., Simone C., Nizzardo M., Magri F., Dametti S., Corti S. Therapeutic development in amyotrophic lateral sclerosis. Clin. Ther. 2015;37:668&#x2013;680. doi: 10.1016/j.clinthera.2014.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.12.020</ArticleId><ArticleId IdType="pubmed">25666449</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D. Edaravone: A new drug approved for ALS. Cell. 2017;171:725. doi: 10.1016/j.cell.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Abati E., Bresolin N., Comi G., Corti S. Advances, challenges, and perspectives in translational stem cell therapy for amyotrophic lateral sclerosis. Mol. Neurobiol. 2019;56:6703&#x2013;6715. doi: 10.1007/s12035-019-1554-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1554-x</ArticleId><ArticleId IdType="pubmed">30911936</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh R.H., Glass J.D., Svendsen C.N. Stem cell transplantation for amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2018;31:655&#x2013;661. doi: 10.1097/WCO.0000000000000598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000598</ArticleId><ArticleId IdType="pubmed">30080719</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z., Leong M.C.-W., Su H., Kwok K.-W., Chan D.T.-M., Poon W.-S. Techniques for stereotactic neurosurgery: Beyond the frame, toward the intraoperative magnetic resonance imaging&#x2013;guided and robot-assisted approaches. World Neurosurg. 2018;116:77&#x2013;87. doi: 10.1016/j.wneu.2018.04.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.04.155</ArticleId><ArticleId IdType="pubmed">29730102</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Ende N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J. Med. 2000;31:21&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">10998753</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Willing A.E., Zigova T., Saporta S., Justen E.B., Lane J.C., Hudson J.E., Chen N., Davis C.D., Sanberg P.R. Intravenous Administration of Human Umbilical Cord Blood Cells in a Mouse Model of Amyotrophic Lateral Sclerosis: Distribution, Migration, and Differentiation. J. Hematotherapy Stem Cell Res. 2003;12:255&#x2013;270. doi: 10.1089/152581603322022990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/152581603322022990</ArticleId><ArticleId IdType="pubmed">12857367</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Sanberg C.D., Kuzmin-Nichols N., Willing A.E., Gemma C., Bickford P.C., Miller C., Rossi R., Sanberg P.R. Human umbilical cord blood treatment in a mouse model of ALS: Optimization of cell dose. PLoS ONE. 2008;3:e2494. doi: 10.1371/journal.pone.0002494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002494</ArticleId><ArticleId IdType="pmc">PMC2429976</ArticleId><ArticleId IdType="pubmed">18575617</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S.A., Savelieff M.G., Sakowski S.A., Feldman E.L. Stem cell treatments for amyotrophic lateral sclerosis: A critical overview of early phase trials. Expert Opin. Investig. Drugs. 2019;28:525&#x2013;543. doi: 10.1080/13543784.2019.1627324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2019.1627324</ArticleId><ArticleId IdType="pmc">PMC6697143</ArticleId><ArticleId IdType="pubmed">31189354</ArticleId></ArticleIdList></Reference><Reference><Citation>Raore B., Federici T., Taub J., Wu M.C., Riley J., Franz C.K., Kliem M.A., Snyder B., Feldman E.L., Johe K. Cervical multilevel intraspinal stem cell therapy: Assessment of surgical risks in Gottingen minipigs. Spine. 2011;36:E164&#x2013;E171. doi: 10.1097/BRS.0b013e3181d77a47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e3181d77a47</ArticleId><ArticleId IdType="pubmed">21099736</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Mareschi K., Ferrero I., Miglioretti M., Stecco A., Servo S., Carriero A., Monaco F., Fagioli F. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: A long-term safety study. Cytotherapy. 2012;14:56&#x2013;60. doi: 10.3109/14653249.2011.613929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14653249.2011.613929</ArticleId><ArticleId IdType="pubmed">21954839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivandzade F., Cucullo L. Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview. Int. J. Mol. Sci. 2021;22:2153. doi: 10.3390/ijms22042153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22042153</ArticleId><ArticleId IdType="pmc">PMC7926761</ArticleId><ArticleId IdType="pubmed">33671500</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemade D., Thyagarajan Subramanian V.S. An update on medical and surgical treatments of Parkinson&#x2019;s disease. Aging Dis. 2021;12:1021&#x2013;1035. doi: 10.14336/AD.2020.1225.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.1225</ArticleId><ArticleId IdType="pmc">PMC8219497</ArticleId><ArticleId IdType="pubmed">34221546</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomishima M., Kirkeby A. Bringing Advanced Therapies for Parkinson&#x2019;s Disease to the Clinic: The Scientist&#x2019;s Perspective. Parkinson's Dis. 2021:1&#x2013;6. doi: 10.3233/JPD-212685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-212685</ArticleId><ArticleId IdType="pubmed">34250954</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C., Westenberger A. Genetics of Parkinson&#x2019;s disease. Cold Spring Harb Perspect Med. 2012;2:a008888. doi: 10.1101/cshperspect.a008888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a008888</ArticleId><ArticleId IdType="pmc">PMC3253033</ArticleId><ArticleId IdType="pubmed">22315721</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L., Chan L.L., Lim E.C., Tan E.K. Stem Cell Replacement Therapies in Parkinson&#x2019;s Disease. Ann. Acad Med. Singap. 2019;48:112&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">31131382</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Tang L., Tang X. Current Developments in Cell Replacement Therapy for Parkinson&#x2019;s Disease. Neuroscience. 2021;463:370&#x2013;382. doi: 10.1016/j.neuroscience.2021.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.03.022</ArticleId><ArticleId IdType="pubmed">33774124</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenas E. Towards stem cell replacement therapies for Parkinson&#x2019;s disease. Biochem. Biophys. Res. Commun. 2010;396:152&#x2013;156. doi: 10.1016/j.bbrc.2010.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.04.037</ArticleId><ArticleId IdType="pubmed">20494130</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchcliffe C., Parmar M. Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies. Parkinson's Dis. 2018;8:S131&#x2013;S137. doi: 10.3233/JPD-181488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-181488</ArticleId><ArticleId IdType="pmc">PMC6311366</ArticleId><ArticleId IdType="pubmed">30584166</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker R.A. Designing stem-cell-based dopamine cell replacement trials for Parkinson&#x2019;s disease. Nat. Med. 2019;25:1045&#x2013;1053. doi: 10.1038/s41591-019-0507-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0507-2</ArticleId><ArticleId IdType="pubmed">31263283</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramana N.K., Kumar S.K., Balaraju S., Radhakrishnan R.C., Bansal A., Dixit A., Rao D.K., Das M., Jan M., Gupta P.K., et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson&#x2019;s disease. Transl. Res. J. Lab. Clin. Med. 2010;155:62&#x2013;70. doi: 10.1016/j.trsl.2009.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2009.07.006</ArticleId><ArticleId IdType="pubmed">20129486</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn T.M., Hallett P.J., Schumacher J.M., Isacson O. Advantages and Recent Developments of Autologous Cell Therapy for Parkinson&#x2019;s Disease Patients. Front. Cell. Neurosci. 2020;14:58. doi: 10.3389/fncel.2020.00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00058</ArticleId><ArticleId IdType="pmc">PMC7147334</ArticleId><ArticleId IdType="pubmed">32317934</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J., Liu Q., Rao M.S., Zeng X. Survival and engraftment of dopaminergic neurons manufactured by a Good Manufacturing Practice-compatible process. Cytotherapy. 2014;16:1305&#x2013;1312. doi: 10.1016/j.jcyt.2014.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2014.06.002</ArticleId><ArticleId IdType="pubmed">25065637</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi J. iPS cell-based therapy for Parkinson&#x2019;s disease: A Kyoto trial. Regen. Ther. 2020;13:18&#x2013;22. doi: 10.1016/j.reth.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reth.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7794047</ArticleId><ArticleId IdType="pubmed">33490319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.W., Koo S.Y., Studer L. Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities. Front. Cell Dev. Biol. 2020;8:729. doi: 10.3389/fcell.2020.00729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00729</ArticleId><ArticleId IdType="pmc">PMC7438741</ArticleId><ArticleId IdType="pubmed">32903681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Ham R.M., Nievaart J.C., Hoekman J., Cooper R.S., Frederix G.W., Leufkens H.G., Klungel O.H., Ovelg&#xf6;nne H., Hoefnagel M.H., Turner M.L. Estimation of manufacturing development costs of cell-based therapies: A feasibility study. Cytotherapy. 2021;23:730&#x2013;739. doi: 10.1016/j.jcyt.2020.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2020.12.014</ArticleId><ArticleId IdType="pubmed">33593688</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosemann A. Stem cell treatments for neurodegenerative diseases: Challenges from a science, business and healthcare perspective. Neurodegener. Dis. Manag. 2015;5:85&#x2013;87. doi: 10.2217/nmt.15.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.15.2</ArticleId><ArticleId IdType="pubmed">25894869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>